Literature DB >> 1829133

Why have we failed to reduce the frequency of cerebral palsy?

F J Stanley1, E Blair.   

Abstract

OBJECTIVE: To review the data on children with cerebral palsy in relation to quality of obstetric care. DATA SOURCES AND STUDY SELECTION: In our Institute, a regular Medline print-out, certain key journals and Current Contents are perused to create an updated computerised file of publications on the epidemiological, aetiological and other aspects of cerebral palsy. For this study we reviewed data from the Western Australian Cerebral Palsy Register, more than 150 publications from which studies were chosen for sound methodology in countries with modern obstetric practices, and recent population data on cerebral palsy. DATA EXTRACTION AND SYNTHESIS: Three major areas were studied to see: (i) if the prevalence of cerebral palsy has fallen with increasing use of obstetric and neonatal interventions aimed at reducing birth asphyxia; (ii) if there is any evidence that cerebral palsy is caused by birth asphyxia; and (iii) if there is any evidence that intrapartum fetal monitoring or caesarean section reduces the prevalence of cerebral palsy.
CONCLUSIONS: We concluded that: cerebral palsy proportions are not falling in spite of significant increases in obstetric and neonatal interventions aimed at reducing asphyxia; cerebral palsy proportions in low birthweight infants are rising in most developed countries, coincident with increases in the neonatal survival of low birthweight babies; few cases of cerebral palsy seem to be caused by birth asphyxia and those that are may not have been preventable by obstetric care; and parents will continue to sue if obstetricians keep promising perfection from obstetric care in the face of 2.0-2.5 cases of cerebral palsy per 1000 children born.

Entities:  

Mesh:

Year:  1991        PMID: 1829133     DOI: 10.5694/j.1326-5377.1991.tb121226.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  11 in total

1.  Disabilities and trends over time in a French county, 1980-91.

Authors:  C Cans; P Guillem; J Fauconnier; P Rambaud; P S Jouk
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

2.  Risk factors for cerebral palsy.

Authors:  S Suvanand; S K Kapoor; V P Reddaiah; U Singh; K R Sundaram
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

3.  Model to identify potentially preventable cerebral palsy of intrapartum origin.

Authors:  G Gaffney; V Flavell; A Johnson; M V Squier; S Sellers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

4.  Trends in perinatal mortality and cerebral palsy in Western Australia, 1967 to 1985.

Authors:  F J Stanley; L Watson
Journal:  BMJ       Date:  1992-06-27

5. 

Authors:  H Schneider
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

6.  Cerebral palsy and neonatal encephalopathy.

Authors:  G Gaffney; V Flavell; A Johnson; M Squier; S Sellers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-05       Impact factor: 5.747

7.  Heterogeneity of neurological syndromes in survivors of grade 3 and 4 periventricular haemorrhage.

Authors:  J P Lin; W Goh; J K Brown; A J Steers
Journal:  Childs Nerv Syst       Date:  1993-07       Impact factor: 1.475

8.  Predictors of neonatal encephalopathy in full-term infants.

Authors:  S J Adamson; L M Alessandri; N Badawi; P R Burton; P J Pemberton; F Stanley
Journal:  BMJ       Date:  1995-09-02

9.  Comparison of single event vs multiple event soft tissue surgeries in the lower extremities with cerebral palsy.

Authors:  Vusal Mahmudov; Huseyin Gunay; Levent Kucuk; Erhan Coskunol; Funda Calis Atamaz
Journal:  J Orthop       Date:  2015-11-14

Review 10.  Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review.

Authors:  Emma L Leach; Michael Shevell; Kristin Bowden; Sylvia Stockler-Ipsiroglu; Clara D M van Karnebeek
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.